Cardiac tamponade epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The cardiac tamponade is most often attributed to the rupture of an acute [[myocardial infarction]] or an intrapericardial rupture of a dissecting ascending [[aortic aneurysm]]. In developed countries malignancy is the leading cause of [[cardiac tamponade]] secondary to [[pericardial effusion]]. | The cardiac tamponade is most often attributed to the rupture of an acute [[myocardial infarction]] or an intrapericardial rupture of a dissecting ascending [[aortic aneurysm]]. In developed countries malignancy is the leading cause of [[cardiac tamponade]] secondary to [[pericardial effusion]]. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence | *The incidence of cardiac tamponade based on a giant sample size of about 216 million emergency admissions was about 115,638(0.05%)<ref name="urlCARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology">{{cite web |url=http://www.onlinejacc.org/content/71/11_Supplement/A1155 |title=CARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology |format= |work= |accessdate=}}</ref> | ||
= | |||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
* | *Cardiac temponade mortality rate is significantly different due to its underlying cause.<ref name="pmid10554845">{{cite journal| author=Porte HL, Janecki-Delebecq TJ, Finzi L, Métois DG, Millaire A, Wurtz AJ| title=Pericardoscopy for primary management of pericardial effusion in cancer patients. | journal=Eur J Cardiothorac Surg | year= 1999 | volume= 16 | issue= 3 | pages= 287-91 | pmid=10554845 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10554845 }} </ref><ref name="urlCARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology" /> | ||
* | *Overall, hospitalized mortality rate is around 14.3% and sub groups with higher mortality are : | ||
*#Sepsis (odds ratio:3.17) | |||
*#Chest trauma (odds ratio:2.15) | |||
*#Metastatic cancer:(odds ratio:1.90) | |||
*#Acute kidney injury(odds ratio:1.91) | |||
*#Idiopathic pericarditis (odds ratio: 0.21, least cause of mortality) <br />s | |||
===Age=== | ===Age=== | ||
*The incidence of | *The incidence of cardiac tamponade increases with age; the mean age was around 61.9.<ref name="urlCARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology" /><ref name="pmid16051963">{{cite journal| author=Gornik HL, Gerhard-Herman M, Beckman JA| title=Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. | journal=J Clin Oncol | year= 2005 | volume= 23 | issue= 22 | pages= 5211-6 | pmid=16051963 | doi=10.1200/JCO.2005.00.745 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16051963 }} </ref> | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to | *There is no racial predilection to cardiac tamponade. | ||
===Gender=== | ===Gender=== | ||
* | *Cardiac tamponade affects men and women equally. | ||
* | *There is no study suggesting a meaningful sex difference among diagnosed patients. | ||
=== | ===Approximate Health Care cost In US=== | ||
* It needs around 12 days of hospitalization and a mean cost of $160,397. | |||
==References== | ==References== | ||
Revision as of 03:50, 15 January 2020
|
Cardiac tamponade Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac tamponade epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cardiac tamponade epidemiology and demographics |
|
Risk calculators and risk factors for Cardiac tamponade epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
The cardiac tamponade is most often attributed to the rupture of an acute myocardial infarction or an intrapericardial rupture of a dissecting ascending aortic aneurysm. In developed countries malignancy is the leading cause of cardiac tamponade secondary to pericardial effusion.
Epidemiology and Demographics
Incidence
- The incidence of cardiac tamponade based on a giant sample size of about 216 million emergency admissions was about 115,638(0.05%)[1]
Case-fatality rate/Mortality rate
- Cardiac temponade mortality rate is significantly different due to its underlying cause.[2][1]
- Overall, hospitalized mortality rate is around 14.3% and sub groups with higher mortality are :
- Sepsis (odds ratio:3.17)
- Chest trauma (odds ratio:2.15)
- Metastatic cancer:(odds ratio:1.90)
- Acute kidney injury(odds ratio:1.91)
- Idiopathic pericarditis (odds ratio: 0.21, least cause of mortality)
s
Age
Race
- There is no racial predilection to cardiac tamponade.
Gender
- Cardiac tamponade affects men and women equally.
- There is no study suggesting a meaningful sex difference among diagnosed patients.
Approximate Health Care cost In US
- It needs around 12 days of hospitalization and a mean cost of $160,397.
References
- ↑ 1.0 1.1 1.2 "CARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology".
- ↑ Porte HL, Janecki-Delebecq TJ, Finzi L, Métois DG, Millaire A, Wurtz AJ (1999). "Pericardoscopy for primary management of pericardial effusion in cancer patients". Eur J Cardiothorac Surg. 16 (3): 287–91. PMID 10554845.
- ↑ Gornik HL, Gerhard-Herman M, Beckman JA (2005). "Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion". J Clin Oncol. 23 (22): 5211–6. doi:10.1200/JCO.2005.00.745. PMID 16051963.